InnovAge Holding Corp

Análisis de la acción InnovAge Holding Corp (INNV)

$10.800

-0.059 (-0.55%)Al cierre

Loading chart…
High
10.890
Open
10.790
VWAP
10.74
Vol
249.77K
Mkt Cap
712.58M
Low
10.540
Amount
2.68M
EV/EBITDA, TTM
-14.64

InnovAge Holding Corp. is a healthcare delivery platform. The Company is engaged in managing the care of high-cost, frail, and dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). Its programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its PACE program, it offers a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center, and third-party medical appointments and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan.

AI analysis of InnovAge Holding Corp (INNV)

hold

InnovAge Holding Corp is currently priced at $10.86 with a forward P/E ratio of 13.66, indicating potential for growth, but it faces significant risks with a recent net loss of $29.46 million in Q3 2026.

Métricas de valoración

The current forward P/E ratio for InnovAge Holding Corp (INNV) is 13.66, compared to its 5-year average forward P/E of -95.41.

Forward P/E

Fair
5Y Average P/E
-95.41
Current P/E
13.66
Sobrevalorada
988.91
Infravalorada
-1179.74

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-7.37
Current EV/EBITDA
-14.64
Sobrevalorada
182.20
Infravalorada
-196.94

Forward P/S

Overvalued
5Y Average P/S
1.00
Current P/S
1.41
Sobrevalorada
1.35
Infravalorada
0.65

Alphio AI Price Scenarios for INNV

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%INNV

$4.78

Precio del escenario

B

Base

Base · 50%INNV

$4.75

Precio del escenario

B

Bear

Bear · 25%INNV

$3.97

Precio del escenario

Whales holding INNV

C

Coliseum Capital Management, LLC

+ HoldingINNV

-20.13%

3M Return

Cronología de eventos

2026-07-31 (ET)

16:30:00

InnovAge Files to Sell 112.99M Shares of Common Stock

2026-05-12 (ET)

16:40:00

InnovAge Appoints Jennifer Browne as President and COO

2026-02-05 (ET)

08:50:00

InnovAge Meets Colorado Lawmakers to Emphasize Importance of Senior Care

2026-02-03 (ET)

16:50:00

Company Raises EBITDA Guidance to $70M-$75M

16:50:00

InnovAge Reports Q2 Revenue of $239.7M

Noticias

INNV FAQ — answered by Alphio AI

InnovAge Holding Corp. is a healthcare delivery platform. The Company is engaged in managing the care of high-cost, frail, and dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). Its programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its PACE program, it offers a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center, and third-party medical appointments and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

InnovAge Holding Corp is currently priced at $10.86 with a forward P/E ratio of 13.66, indicating potential for growth, but it faces significant risks with a recent net loss of $29.46 million in Q3 2026.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis